维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Patrick Amoth"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	SARS-CoV-2/COVID-19 laboratory biosafety practices and current molecular diagnostic tools显示文摘The ongoing severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)/coronavirus disease 2019(COVID-19)pandemic has crippled several countries across the globe posing a serious global public health challenge.Despite the massive rollout of vaccines,molecular diagnosis remains the most important method for timely isolation,diagnosis,and control of COVID-19.Several molecular diagnostic tools have been developed since the beginning of the pandemic with some even gaining emergency use authorization from the United States(US)Food and Drug Administration for in vitro diagnosis of SARS-CoV-2.Herein,we discuss the working principles of some commonly used molecular diagnostic tools for SARS-CoV-2 including nucleic acid amplification tests,isothermal amplification tests,and rapid diagnostic tests.To ensure successful detection while minimizing the risk of cross-infection and misdiagnosis when using these diagnostic tools,laboratories should adhere to proper biosafety practices.Hence,we also present the common biosafety practices that may ensure the successful detection of SARS-CoV-2 from specimens while protecting laboratory workers and non-suspecting individuals from being infected.From this review article,it is clear that the SARS-CoV-2 pandemic has led to an increase in molecular diagnostic tools and the formation of new biosafety protocols that may be important for future and ongoing outbreaks.	Raphael Nyaruaba Caroline Mwaliko Wei Hong Patrick Amoth Hongping Wei	2021	Journal of Biosafety and Biosecurity2021，3，2：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费